[ad_1]
<div id = "firstBodyDiv" data-bind-html-content-type = "article" data-bind-html-compile = "article.body" data-first-article-body = "
According to the website "News Max", the new treatment contains a type of industrial protein called interleukin or IL-15, where the injection is injected into the tumor, which increases the number of immune cells struggling with difficulties. Cancer And leads to the destruction of malignant cells and reduce tumors.
Through clinical trials, scientists hope that the protein will not only reduce tumors, but will also provide permanent protection against the disease so that it does not return.
According to a previous report in the newspaper "Courrier quotidien" In the United Kingdom, human cells naturally contain the IL-15 protein, while the reinjection of proteins helps to improve its levels, which favors the Immune system In his war against cancer cells.
Prostate cancer causes the death of three quarters of men infected at an advanced stage, within 4 years of infection.
The researchers hope the new technology will help prevent the spread of cancer to other organs and prevent medical complications.
According to a prominent researcher from the "Kings College" Krissin Galustian, early laboratory experiments showed that IL-15 was able to reduce the size Oncology More than half.
She added, "He has the ability to change the rules of the game for men with prostate cancer."
According to estimates by the American Cancer Society, more than 164,000 people a year would have prostate cancer in the United States in 2018, while the association predicted some 30,000 deaths.
">
According to NewsMax, the new treatment contains an industrial protein called interleukin or IL-15, which injects the tumor into the tumor, increasing the number of immune cells that fight cancer and kill malignant cells and reduce tumors.
Through clinical trials, scientists hope that the protein will not only reduce tumors, but will also provide permanent protection against the disease so that it does not return.
According to a previous report published in the Daily Mail, human cells naturally contain the protein IL-15, while the reinjection of proteins helps to increase its levels, which supports the immune system in its fight against cancer cells.
Prostate cancer causes the death of three quarters of men infected at an advanced stage, within 4 years of infection.
The researchers hope the new technology will help prevent the spread of cancer to other organs and prevent medical complications.
According to Christine Galustian, a senior researcher at King's College, early laboratory experiments have shown that IL-15 was able to reduce tumors by more than half.
"He has the ability to change the rules of the game in men with prostate cancer."
According to estimates by the American Cancer Society, more than 164,000 people a year would have prostate cancer in the United States in 2018, while the association predicted some 30,000 deaths.
